IDEXX Laboratories, Inc. (IDXX) Stock Price: $556.94-21.95 (-3.79%)
At close: Jun 10, 2026, 4:00 PM ET
The closing share price for IDEXX Laboratories, Inc. (IDXX) stock was $556.94 for Wednesday, June 10, 2026, down 3.79% on the day.
Longer view (total return, dividends reinvested): past 12 months +5.7% · 3-year avg +7.1%/yr · 5-year avg -1.1%/yr
IDXX Price Chart
IDXX Key Metrics
See All MetricsIDXX Earnings Preview
Next Earnings Date
Aug 3, 2026
53 days away
EPS Estimate
3.95
Revenue Est.
$1.20B
Last Quarter Results
EPS
$3.47
vs Estimate
$3.41
Revenue
$1.14B
vs Estimate
$1.12B
IDXX Analyst Ratings
Consensus Rating
Based on 14 analysts
Average Price Target
$709.14
+27.3% upside
Low
$470.00
Current
$556.94
High
$805.00
IDXX Analyst Estimates
Earnings Per Share (EPS) Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q2 2027 | $4.42 | $4.44 | $4.49 | 5 |
| Q3 2027 | $4.22 | $4.25 | $4.29 | 3 |
| Q4 2027 | $3.90 | $3.92 | $3.96 | 6 |
| Q1 2028 | $4.33 | $4.36 | $4.40 | 4 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | $16.24 | $16.57 | $16.92 | 10 |
| FY 2028 | $17.91 | $18.76 | $19.77 | 8 |
Revenue Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q2 2027 | $1.29B | $1.30B | $1.31B | 3 |
| Q3 2027 | $1.29B | $1.30B | $1.30B | 3 |
| Q4 2027 | $1.27B | $1.28B | $1.29B | 3 |
| Q1 2028 | $1.30B | $1.31B | $1.32B | 2 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | $5.10B | $5.12B | $5.16B | 11 |
| FY 2028 | $5.58B | $5.59B | $5.59B | 11 |
Source: FMP Analyst Consensus Estimates. Forward P/E calculated using average EPS estimate for the nearest fiscal year.
IDXX Competitors' Key Metrics
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| 1IDXX | $43.84B | $556.94 | -3.79% | +5.73% | -1.06% | +20.08% |
IDXX Charts
Valuation Charts
Performance Charts
CAGR Charts
Financial Statement Charts
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- Capital Expenditure
- Acquisitions
- Share Buybacks
- Stock-Based Compensation
- Total Assets
- Total Equity
- Cash & Equivalents
- Accounts Receivable
- Inventory
- PP&E
- Goodwill
- Accounts Payable
- Retained Earnings
- Total Debt
- Long-Term Debt
- Short-Term Debt
About IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Jonathan J. Mazelsky